38 results on '"EGAN, BRENT M."'
Search Results
2. Differences in primary cardiovascular disease prevention between the 2013 and 2016 cholesterol guidelines and impact of the 2017 hypertension guideline in the United States
3. Measure Accurately, Act Rapidly, and Partner With Patients (MAP) improves hypertension control in medically underserved patients: Care Coordination Institute and American Medical Association Hypertension Control Project Pilot Study results
4. Opportunities for improving cardiovascular health outcomes in adults younger than 65 years with guideline-recommended statin therapy
5. Low Blood Pressure Is Associated With Greater Risk for Cardiovascular Events in Treated Adults With and Without Apparent Treatment-Resistant Hypertension
6. Abnormalities of Anthropometric, Hemodynamic, and Autonomic Variables in Offspring of Hypertensive Parents
7. Blood Pressure Control Provides Less Cardiovascular Protection in Adults With Than Without Apparent Treatment-Resistant Hypertension
8. Impact of Implementing the 2013 ACC/AHA Cholesterol Guidelines on Vascular Events in a Statewide Community-Based Practice Registry
9. Elijah Saunders in Memoriam
10. Hypertension in African Americans Aged 60 to 79 Years: Statement From the International Society of Hypertension in Blacks
11. Antihypertensive Medication Persistence 1-Year Post-Stroke Hospitalization
12. Formation of Community-Based Hypertension Practice Networks: Success, Obstacles, and Lessons Learned
13. Epithelial Sodium Channel Inhibition by Amiloride on Blood Pressure and Cardiovascular Disease Risk in Young Prehypertensives
14. Blood Pressure Reclassification in Adolescents Based on Repeat Clinic Blood Pressure Measurements
15. Different Definitions of Prevalent Hypertension Impact: The Clinical Epidemiology of Hypertension and Attainment of Healthy People Goals
16. Impact of the Number of Blood Pressure Measurements on Blood Pressure Classification in US Adults: NHANES 1999–2008
17. Does Response of RAS Blockade on Serum K+ Levels Influence Its Glycemic-Mitigating Response When Combined With Hydrochlorothiazide?
18. Office and Ambulatory Blood Pressure-Lowering Effects of Combination Valsartan/Hydrochlorothiazide vs Hydrochlorothiazide-Based Therapy in Obese, Hypertensive Patients
19. Impacting Population Cardiovascular Health Through a Community‐Based Practice Network: Update on an ASH‐Supported Collaborative
20. Measuring the Impact of a Continuing Medical Education Program on Patient Blood Pressure
21. Antihypertensive Medication Prescribing Patterns in a University Teaching Hospital
22. An Evaluation of the Effects of an Angiotensin Receptor Blocker on Health‐Related Quality of Life in Patients With High‐Normal Blood Pressure (Prehypertension) in the Trial of Preventing Hypertension (TROPHY)
23. Combination Therapy With an Angiotensin-Converting Enzyme Inhibitor and a Calcium Channel Blocker
24. Cardiovascular Risk Factor Control in Communities?Update From the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network
25. The Effect of Extended-Release Metoprolol Succinate on C-Reactive Protein Levels in Persons With Hypertension
26. Challenges and Risks in Attaining the Systolic Blood Pressure Goal of <130 mm Hg in All Diabetic Patients
27. Platelet and White Blood Cell Counts Are Elevated in Patients With the Metabolic Syndrome
28. Ethnic Differences in the Treatment and Control of Hypertension in Patients With Diabetes
29. Cardioprotection: The Role of β‐Blocker Therapy
30. Gender‐ and Age‐Related Differences in Treatment and Control of Cardiovascular Risk Factors Among High‐Risk Patients With Angina
31. Excessive Alcohol Consumption and Hypertension: Clinical Implications of Current Research
32. Elevation of C‐Reactive Protein in People With Prehypertension
33. An Assessment of Racial Differences in Clinical Practices for Hypertension at Primary Care Sites for Medically Underserved Patients
34. A Statewide Primary Care Approach to Cardiovascular Risk Factor Control in High‐Risk Diabetic and Nondiabetic Patients With Hypertension
35. Low Birth Weight as a Risk Factor for Hypertension
36. Moderate Sodium Restriction Enhances the Pressor Response to Hyperlipidemia in Obese, Hypertensive Patients
37. Health Care Improvement and Cost Reduction Opportunities in Hypertensive Medicaid Beneficiaries
38. Low Birth Weight Contributes to the Excess Prevalence of End-Stage Renal Disease in African Americans
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.